Abstract
Clinical experience in vascularized composite allotransplantation (VCA) is accumulating, with about 25 % of the clinical cases now five or more years posttransplantation. To date, few centers have reported sequelae related to chronic rejection, and in fact, some centers have reported a clear lack of chronic rejection. Unfortunately, our center has had experience with graft vasculopathy in hand transplant recipients, and other characteristics of chronic rejection such as thinning of the skin and loss of adnexal structures have presented in one of our patients. In this chapter, we briefly review chronic rejection in solid organ transplantation and apply lessons learned to what is being presented by VCA recipients. The early experience suggests that VCA patients may be somewhat protected from chronic rejection, but that it can occur, and unlike solid organ transplants there may be multiple primary tissue targets. Like solid organ transplantation, the development of tolerance-inducing protocols with control of both acute and chronic rejection with reduced or no systemic immunosuppression is needed. It remains to be seen whether conventional immunosuppression will be any more effective in treating chronic rejection in VCA patients than it has been for solid organ recipients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009;15(21):2561–9.
Azuma H, Tullius SG, Heemann UW, Tilney NL. Nonimmune factors may contribute to chronic rejection of kidney transplants. Transplant Proc. 1994;26(4):2109–10. (Available from: PM:8066686)
Brandacher G, Lee WP, Schneeberger S. Minimizing immunosuppression in hand transplantation. Expert Rev Clin Immunol. 2012;8(7):673–83.
Brenner MJ, Tung TH, Jensen JN, Mackinnon SE. The spectrum of complications of immunosuppression: is the time right for hand transplantation? J Bone Joint Surg Am. 2002;84-A(10):1861–70. (Available from: PM:12377920)
Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, Wilkes DS. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest. 2007;117(11):3498–506.
Cendales LC, Kanitakis J, Schneeberger S, Burns C, Ruiz P, Landin L, Remmelink M, Hewitt CW, Landgren T, Lyons B, Drachenberg CB, Solez K, Kirk AD, Kleiner DE, Racusen L. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8(7):1396–400.
Christensen J, Ibrahim Z, Wu L, Leto Barone A, Furtmuller M, Sarhane K, Al-Rakan M, Schneeberger S, Shores JT, Bonawitz S, Cooney D, Sacks J, Lee WP, Brandacher G. Mechanical trauman can reactivate an alloimmune response against the skin component in a large animal vascularized composite allotransplantation (VCA) model of operational tolerance. Am Transpl Congr 2013;13[S5]:203.
Clatworthy MR. B Cell responses to allograft—more common than we thought? Am J Transplant. 2013;13(7):1629–30.
Clatworthy MR, Espeli M, Torpey N, Smith KG. The generation and maintenance of serum alloantibody. Curr Opin Immunol. 2010;22(5):669–81. (Available from: PM:20932734)
Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, Czaja A, Daskal I, El-Monayeri MS, Fontes P, Fung J, Gridelli B, Guido M, Haga H, Hart J, Honsova E, Hubscher S, Itoh T, Jhala N, Jungmann P, Khettry U, Lassman C, Ligato S, Lunz JG, III, Marcos A, Minervini MI, Molne J, Nalesnik M, Nasser I, Neil D, Ochoa E, Pappo O, Randhawa P, Reinholt FP, Ruiz P, Sebagh M, Spada M, Sonzogni A, Tsamandas AC, Wernerson A, Wu T, Yilmaz F. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006;44(2):489–501.
Diefenbeck M, Nerlich A, Schneeberger S, Wagner F, Hofmann GO. Allograft vasculopathy after allogeneic vascularized knee transplantation. Transpl Int. 2011;24(1):e1–5. (Available from: PM:20958796)
Edelman ER, Danenberg HD. Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds? Circulation 2003;108(1):6–8. (Available from: PM:12847052)
Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324(10):667–74. (Available from: PM:1994250)
Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009;373(9674):1550–61.
Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A. 1989;86(21):8412–8416. (Available from: PM:2813399)
Giovanelli M, Gupte GL, Sharif K, Mayer DA, Mirza DF. Chronic rejection after combined liver and small bowel transplantation in a child with chronic intestinal pseudo-obstruction: a case report. Transpl Proc. 2008;40(5):1763–67.
Hancock WH, Whitley WD, Tullius SG, Heemann UW, Wasowska B, Baldwin WM III, Tilney NL. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation. 1993;56(3):643–50.
Heemann U, Lutz J. Pathophysiology and treatment options of chronic renal allograft damage. Nephrol Dial Transpl. 2013;28(10):2438–46.
Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, Sellares J, Reeve J, Halloran PF. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant. 2009;9(11):2532–41.
Holbro A, Lehmann T, Girsberger S, Stern M, Gambazzi F, Lardinois D, Heim D, Passweg JR, Tichelli A, Bubendorf L, Savic S, Hostettler K, Grendelmeier P, Halter JP, Tamm M. Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(6):973–80.
Hornick P, Rose M. Chronic rejection in the heart. Methods Mol Biol. 2006;333:131–44.
Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation–is it reversible? Transplantation. 1991;51(5):1004–10.
Jensen JN, Mackinnon SE. Composite tissue allotransplantation: a comprehensive review of the literature–Part II. J Reconstr Microsurg. 2000;16(2):141–57.
Joosten SA, van KC, Paul LC. Pathogenesis of chronic allograft rejection. Transpl Int. 2003;16(3):137–45.
Kanitakis J, McGregor B, Badet L, Petruzzo P, Morelon E, Devauchelle B, Dubernard JM. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation 2007;84(2):265–7. (Available from: PM:17667820)
Kaufman CL, Marvin MR, Ouseph R, Manon-Matos Y, Blair B, Kutz JE. Evidence for chronic rejection of the skin and adnexal structures in a hand transplant recipient at six years post transplant without significant graft vasculopathy. Am J Transplant. 2013;13[S5]:286.
Kaufman CL, Ouseph R, Blair BW, Kutz JE, Tsai TM, Scheker LR, Tien HY, Moreno R, Ozyrekoglu T, Banegas R, Murphy EE, Burns C, Zavan B, Cook DF, Marvin MR. Graft vasculopathy in clinical hand transplantation. Am J Transplant. 2012;12(4):1004–16.
Khan MS, Heinle JS. Pediatric thoracic multiorgan transplantation. Tex Heart Inst J. 2012;39(6):850–1.
Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966;2(7465):662–5.
Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450–62.
Landin L, Cavadas PC, Ibanez J, Roger I, Vera-Sempere F. CD3 + -mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 2009;87(5):776–81. (Available from: PM:19295326)
Lanzetta M, Petruzzo P, Margreiter R, Dubernard JM, Schuind F, Breidenbach W, Lucchina S, Schneeberger S, van HC, Granger D, Pei G, Zhao J, Zhang X. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2005;79(9):1210–4. (Available from: PM:15880072)
Lineaweaver WC. Chronic rejection, hand transplantation, and the monkey’s paw. Microsurgery. 2006;26(6):419–20.
Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant. 2011;11(6):1226–35.
Lynch RJ, Silva I, Chen BJ, Punch JD, Cascalho M, Platt JL. Cryptic B cell response to renal transplantation. Am J Transplant. 2013;13(7):1713–23.
Mitchell RN. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol. 2009;4:19–47. (Available from: PM:18717641)
Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100(7):967–78. (Available from: PM:17431198)
Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation. 2012;93(9):855–9.
Mundinger GS, Munivenkatappa R, Drachenberg CB, Ha JS, Vaca EE, Shipley ST, Papadimitriou JC, Bartlett ST, Rodriguez ED, Barth RN. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation. Transplantation 2013;95(10):1204–10.
Murphy BD, Zuker RM, Borschel GH. Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges. J Plast Reconstr Aesthet Surg. 2013;(13):10.
Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011;378(9800):1428–37.
Orloff SL, Hwee YK, Kreklywich C, Andoh TF, Hart E, Smith PA, Messaoudi I, Streblow DN. Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naive recipients. Am J Transplant. 2011;11(1):45–55. (Available from: PM:21199347)
Petruzzo P, Lanzetta M, Dubernard JM, Landin L, Cavadas P, Margreiter R, Schneeberger S, Breidenbach W, Kaufman C, Jablecki J, Schuind F, Dumontier C. The international registry on hand and composite tissue transplantation. Transplantation. 2010;90(12):1590–4. (Available from: PM:21052038)
Petruzzo P, Kanitakis J, Badet L, Pialat JB, Boutroy S, Charpulat R, Mouly J, Gazarian A, Lanzetta M, Brunet M, Devauchelle B, Testelin S, Martin X, Dubernard JM, Morelon E. Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients. Am J Transplant. 2011;11(4):808–16. (Available from: PM:21446980)
Pinderski LJ, Kirklin JK, McGiffin D, Brown R, Naftel DC, Young KR Jr., Smith K, Bourge RC, Tallaj JA, Rayburn BK, Benza R, Zorn G, Leon K, Wille K, Deierhoi M, George JF. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transpl. 2005;24(11):1828–33.
Rana A, Robles S, Russo MJ, Halazun KJ, Woodland DC, Witkowski P, Ratner LE, Hardy MA. The combined organ effect: protection against rejection? Ann Surg. 2008;248(5):871–9.
Reichman TW, Marino SR, Milner J, Harland RC, Cochrane A, Millis JM, Testa G. Acute humoral rejection in an ABO compatible combined liver-kidney transplant–the kidney is not always protected. Am J Transplant. 2009;9(8):1957–60.
Reischig T. Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies. Expert Rev Anti Infect Ther. 2010;8(8):903–10.
Sirois MG, Simons M, Kuter DJ, Rosenberg RD, Edelman ER. Rat arterial wall retains myointimal hyperplastic potential long after arterial injury. Circulation 1997;96(4):1291–8. (Available from: PM:9286961)
Sivakumar B, Haloob N, Puri A, Latif A, Ghani S, Brough V, Molloy J, Clarke A, Denton CP, Butler PE. Systemic sclerosis as a model of chronic rejection in facial composite tissue transplantation. J Plast Reconstr Aesthet Surg. 2010;63(10):1669–76.
Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8(4):753–60.
Starzl TE, Marchioro TL, Rifkind D, Rowlands DT Jr, Waddell WR. Clinical experience with organ transplantation. South Med J. 1965;58:131–47.
Sumpter TL, Wilkes DS. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol. 2004;286(6):L1129–39.
Terasaki PI, Marchioro TL, Starzl TE. Sero-typing of human lymphocyte antigens: preliminary trials on long term kidney homograft surviviors. First Histocompatibility Workshop, 83. 1964.
Tilney NL. Renal transplantation between identical twins: a review. World J Surg. 1986;10(3):381–8.
Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest. 2011;140(2):502–8.
Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, Magyar WA, Hobbs RE, Starling RC, Young JB, McCarthy P, Nissen SE. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol. 2005;45(9):1538–42. (Available from: PM:15862431)
Unadkat JV, Schneeberger S, Horibe EH, Goldbach C, Solari MG, Washington KM, Gorantla VS, Cooper GM, Thomson AW, Lee WP. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant. 2010;10(2):251–61. (Available from: PM:20041866)
Weigt SS, Wallace WD, Derhovanessian A, Saggar R, Saggar R, Lynch JP, Belperio JA. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment. Semin Respir Crit Care Med. 2010;31(2):189–207.
Weiss MJ, Madsen JC, Rosengard BR, Allan JS. Mechanisms of chronic rejection in cardiothoracic transplantation. Front Biosci. 2008;13:2980–8. (Available from: PM:17981771)
Win TS, Pettigrew GJ. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation. 2010;90(2):113–20.
Yamani MH, Yousufuddin M, Starling RC, Tuzcu M, Ratliff NB, Cook DJ, Abdo A, Crowe T, Hobbs R, Rincon G, Bott-Silverman C, McCarthy PM, Young JB. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant. 2004;23(3):272–6.
Yates PJ, Nicholson ML. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol. 2006;16(3–4):148–57.
Zeevi A, Morel P, Spichty K, Dauber J, Yousem S, Williams P, Grgurich W, Pham S, Iacono A, Keenan R, Duquesnoy R, Griffith B. Clinical significance of CMV-specific T helper responses in lung transplant recipients. Hum Immunol. 1998;59(12):768–75.
Acknowledgments
The authors would like to acknowledge the Department of Defense, Office of Army Research, and the Office of Naval Research as well as the Jewish Hospital Foundation, the Kleinert Kutz Hand Care Center, and the Christine M. Kleinert Institute for Hand and Microsurgery for support of these studies.
Disclosure: The authors do not have any conflicts to disclose regarding this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kaufman, C. et al. (2015). Chronic Rejection in Reconstructive Transplantation. In: Brandacher, G. (eds) The Science of Reconstructive Transplantation. Stem Cell Biology and Regenerative Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2071-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2071-6_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2070-9
Online ISBN: 978-1-4939-2071-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)